Product Description: KDM2B-IN-1 is a histone demethylase (kdm2b) inhibitor and can be used for hyperproliferative diseases research[1].
Applications: COVID-19-immunoregulation
Formula: C21H30N4O2S
References: [1]Brian K. Albrecht, et al. 4,5-dihydroimidazole derivatives and their use as histone demethylase (kdm2b) inhibitors. Patent WO2016112251A1.
CAS Number: 1965248-33-2
Molecular Weight: 402.55
Compound Purity: 99.19
Research Area: Cancer; Inflammation/Immunology
Solubility: DMSO : 5 mg/mL (ultrasonic;warming;heat to 60°C)